Trawspharma
NASDAQ: TRAW1 known investors
Traws Pharma is a clinical-stage biopharmaceutical company developing oral small molecule antiviral therapies for respiratory viral diseases. Its pipeline includes Ratutrelvir, a ritonavir-independent treatment for COVID-19/Long COVID, and Tivoxavir marboxil, a single-dose treatment for bird flu and seasonal influenza.
Investors · 1
Competitors · 6
by search overlap
Robinhood16 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Public16 shared keywordsPublic is a trading platform that allows users to buy and sell cryptocurrencies including Bitcoin, Ethereum, and memecoins through accounts managed by Zero Hash LLC, a New York State-licensed virtual currency business.
Simply Wall St15 shared keywordsSimply Wall St is a stock analysis platform that provides portfolio insights, stock discovery tools, and market alerts for individual investors. The service offers institutional-grade financial data visualization and analysis across 120,000 global stocks.
TradingView15 shared keywordsTradingView is a charting platform and social network used by over 100 million traders and investors worldwide to analyze and trade across global financial markets. The platform provides tools for technical analysis, market data, and community collaboration for retail and institutional traders.
StockTwits15 shared keywordsStocktwits is a social platform for investors and traders to share market news, discussions, sentiment polls, and live financial content. It aggregates breaking market news, equity coverage, and community discussions around individual stocks and crypto.
Seeking Alpha13 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
Companies competing with Trawspharma for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Trawspharma do?
- Traws Pharma is a clinical-stage biopharmaceutical company developing oral small molecule antiviral therapies for respiratory viral diseases. Its pipeline includes Ratutrelvir, a ritonavir-independent treatment for COVID-19/Long COVID, and Tivoxavir marboxil, a single-dose treatment for bird flu and seasonal influenza.
- Who are Trawspharma's investors?
- Trawspharma's investors include OrbiMed.